Jonas Johnsen-Dyhrfjeld - Publications

Pharmacological Approaches to Hearing Loss.

Journal: Pharmacological reviews

Published: February 14, 2024

Current Clinical Trials for Tinnitus: Drugs and Biologics.

Journal: Otolaryngologic clinics of North America

Published: April 27, 2020

Medicine in the Fourth Dimension.

Journal: Cell metabolism

Published: April 02, 2019

Morphological and functional correlates of vestibular synaptic deafferentation and repair in a mouse model of acute-onset vertigo.

Journal: Disease models & mechanisms

Published: January 29, 2019

SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: December 21, 2018

An update: emerging drugs for tinnitus.

Journal: Expert opinion on emerging drugs

Published: December 08, 2018

Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.

Journal: British journal of pharmacology

Published: August 27, 2018

Management of peripheral vertigo with antihistamines: New options on the horizon.

Journal: British journal of clinical pharmacology

Published: July 06, 2018

Noise-induced trauma produces a temporal pattern of change in blood levels of the outer hair cell biomarker prestin.

Journal: Hearing research

Published: June 28, 2018

Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: August 11, 2017

Outer Hair Cell Molecular Protein, Prestin, as a Serum Biomarker for Hearing Loss: Proof of Concept.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: September 17, 2016

Ondansetron reduces lasting vestibular deficits in a model of severe peripheral excitotoxic injury.

Journal: Journal of vestibular research : equilibrium & orientation

Published: November 02, 2013